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LETTERS TO THE EDITOR 
Renovascular Disease in the Elderly 
I believe that Olin et al. (1) may have misinterpreted the conclu•
sions of the ~tudy performed in our institution and published in 
1980 (2). and I would therefore appreciate the opportunity to restate 
our position on this ~ubJect. 
Olin et al. state: "Some investigators (quoting our study [2]) 
~uggest that blood pressure control after renal revascularization is 
dIrectly related to the age of the patient at the time of operation 
and therefore contend that renovascular surgery should be limited 
to patients under 50 to 55 years because the chance of curing 
hyperten~ion is small and the mortality rate is high." 
Although we found in our study (2) that older patients had a 
poorer blood pressure response, we did state that "we would still 
recommend, if other intra-abdominal surgery is required, that con•
comitant renova~cular reconstruction be performed for preservation 
of renal function and possible improvement of hypertension. Sim•
ilarly, in older patients with severe uncontrollable hypertension 
and a high grade renal artery stenosis, operation may be justified 
de~pite the greater risk of a poor response. " 
The principal reason for our recommendation against surgery, 
unless there were pressing indications, was neither the surgical 
risk (which wa~ 0% for i~olated renal surgery in our older group 
of patient~) nor the less favorable blood pressure response in the 
elderly. Rather, it was the fact that even in older patients in whom 
good blood pressure control was achieved, when hypertension had 
been chrome, long-term patient survival rates did not appear to be 
altered by succe~sful surgery. This is graphically shown in our 
FIgure 2 (2), where the survival curves for postoperative normo•
ten~ive subjects over 50 years of age and postoperative patients 
with ~evere hypertension over 50 years of age were almost 
~uperimposable . 
In the 21 patients treated surgically in the report of Olin et ai., 
the operative mortality was 4%. The short-term cure rate was 
quoted to be 25% WIth an improved rate of 65%. As shown in our 
study, the longer-term rates tend to be less satisfactory and, with 
time, an approximately 30% deterioration in the cured/improved 
rate can be expected. 
The comparison between the medical and surgical groups (I) 
~hould also be viewed the some caution. Although in Table 1 (1) 
the target organ mvolvement is listed as not statistically signifi•
cantly different among the groups, Table 5 shows that four of six 
patients in the medical mortality group but none in the surgical 
group had had a previous myocardial infarction. Furthermore, the 
three patients in the medical mortality group who had had cardiac 
catheterization all showed severe disease, whereas in two of the 
four in the surgical group who had catheterization there was mild 
disease. Clearly, in a retrospective study of this type some selection 
factors must have played a role in choosing the therapy. 
The principal reason for treating hypertension surgically is that 
pallents WIth ~Ignificant hypertension are prone to premature mor•
tality from ischemic heart disease, stroke or renal insufficiency. I 
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believe that a comparison of the data presented by Olin et al. (1) 
with the large number of patients we followed up to 25 years after 
operation shows that their study fails to demonstrate any benefit 
in regard to survival or reduction in morbidity in their older pop•
ulation. We would certainly concur that patients who are under 
poor medical control should be offered surgery if this appears 
feasible. However, we would caution against performing reno•
vascular surgery in elderly patients simply to improve blood pres•
sure recordings in the absence of any evidence that many of these 
patients will not continue to experience excessive mortality from 
pre-existing atherosclerotic lesions. 
We agree with the authors' recommendation that if hypertension 
is resistant to medical therapy, or a patient experiences undesirable 
side effects from medication or if renal function is jeopardized, 
surgical therapy should be considered. Nonetheless, there is a 
substantial preponderance of evidence in larger groups of patients 
suggesting that the outcome in the elderly is likely to be less 
favorable in terms of both relief of hypertension and significant 
impact on truly late mortality rates. Therefore, it would seem that 
one should continue to exercise a greater degree of selectivity in 
the choice of the patient who is to undergo renovascular surgery 
in this age group. 
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Reply 
Although there are similarities between our report and the earlier 
excellent report of Lawrie et ai., several significant differences 
must also be noted. 
Both reports are retrospective studies and some selection factors 
did play a role in choosing therapy in both series. The surgical 
mortality rate for isolated renal surgery was 0% in both series. 
The one perioperative death in our series (4%) occurred in a patient 
who had undergone resection of an abdominal aneurysm and renal 
revascularization. In the series of Lawrie and colleagues, the peri•
operative mortality rate was 4.8% when an associated vascular 
procedure was performed at the time of renal revascularization. 
Lawrie and colleagues considered surgery for patients with severe 
hypertension unresponsive to or poorly controlled with medical 
therapy. In our series, surgery or percutaneous transluminal an•
gioplasty was considered for patients with poorly controlled blood 
